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MINI ABSTRACT 
Purpose/Introduction 
In the UK, fracture risk guidance is provided by the National Osteoporosis Guideline Group 
(NOGG). NOGG usage showed widespread access through direct web-based linkage to FRAX.  
The facilitated interaction between fracture risk assessment and clinical guidelines could 
usefully be adopted in other countries. 
 
ABSTRACT 
Purpose/Introduction 
In the UK, guidance on assessment of osteoporosis and fracture risk is provided by the 
National Osteoporosis Guideline Group (www.shef.ac.uk/NOGG). We wished to determine 
access to this guidance by exploring website activity. 
Methods 
We undertook an analysis of FRAX and NOGG website usage for the year between 1st July 
2013 and 30th June 2014 using GoogleAnalytics software.   
Results 
During this period, there was a total of 1,774,812 sessions (a user interaction with the 
website) on the FRAX website with 348,964 of these from UK-based users; 253,530 sessions 
were recorded on the NOGG website.  Of the latter, two-thirds were returning visitors, with 
the vast majority (208,766, 82%) arising from sites within the UK.  The remainder of sessions 
were from other countries demonstrating that some users of FRAX in other countries make 
use of the NOGG guidance.  Of the UK-sourced sessions, the majority were from England, 
but the session rate (adjusted for population) was highest for Scotland.  Almost all (95.7%) of 
the UK sessions arose from calculations being passed through from the FRAX tool 
(www.shef.ac.uk/FRAX) to the NOGG website, comprising FRAX calculations in patients 
without a BMD measurement (74.5%) or FRAX calculations with a BMD result (21.2%).  
National Health Service (NHS) sites were identified as the major source of visits to the NOGG 
website, comprising 79.9% of the identifiable visiting locations, but this is an underestimate 
as many sites from within the NHS are not classified as such. 
Conclusion 
The study shows that the facilitated interaction between web based fracture risk assessment 
and clinical guidelines is widely used in the UK.  The approach could usefully be adopted in 
other countries for which a FRAX model is available. 
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BACKBROUND AND AIMS 
FRAX, an online algorithm (www.shef.ac.uk/FRAX) to determine an ŝŶĚŝǀŝĚƵĂů ?Ɛ10-year 
fracture probability, has been available since April 2008.  It integrates the weight of 
important clinical risk factors for fracture and mortality risk, with or without information on 
BMD, and is now available for 57 countries potentially covering 79% of the global population 
age 50 years or more.  FRAX is now incorporated into many national and international 
guidelines for the assessment of fracture risk and/or the management of postmenopausal 
and glucocorticoid-induced osteoporosis [1-12].  In the UK, FRAX is one of two fracture risk 
assessment tools included in guidance by the National Institute for Health and Clinical 
Excellence (NICE) and the Scottish Intercollegiate Guideline Network (SIGN)[13, 14].    
In late 2008, the National Osteoporosis Guideline Group (NOGG) in the UK provided FRAX-
based guidance and thresholds for the assessment of BMD and the need for therapeutic 
intervention[15] with a further update in 2013[16].  The NOGG guidance was also provided 
in an online format (www.shef.ac.uk/NOGG) and linked to the FRAX UK calculation tool by a 
button that could be pressed by the individual undertaking the risk assessment; this system 
remains in place today.  In the absence of BMD input to the FRAX calculation, this action 
transfers the probability of major osteoporotic fracture (hip, clinical vertebra, wrist and 
proximal humerus) to the NOGG algorithm webpage to determine if a patient can be simply 
reassured, initiated on treatment or referred for a BMD measurement for further 
characterization of risk.  In the presence of BMD input, the probabilities of both hip and 
major osteoporotic fracture are transferred to the NOGG algorithm webpage.  Similar 
electronic linkages have now been implemented in several countries (e.g. Finland, Lebanon, 
and Romania), whereby the online output of FRAX is automatically compared to 
independent country-specific guidelines to facilitate treatment decisions according to local 
guidelines.   
The purpose of this study was to undertake an analysis of UK-based usage of the FRAX and 
NOGG websites as an indicator of access to the current guidance.   
 
METHODS 
Both the FRAX website and the NOGG website are monitored using GoogleAnalytics 
software that enables exploration and documentation of website activity, patterns and 
sources.  For this study, we assessed usage of the FRAX and NOGG websites by undertaking 
an analysis of the number of sessions of website activity, and the geographical source of that 
activity, using GoogleAnalytics.  We have used a similar approach in a previous study of 
global FRAX usage[17].  Briefly, GoogleŶĂůǇƚŝĐƐĚĞƚĞƌŵŝŶĞƐůŽĐĂƚŝŽŶƐĨƌŽŵĂǀŝƐŝƚŽƌ ?Ɛ/W
address and counts each visit as a session number.  The data are based not on risk 
calculation count, but on the number of sessions (the latter captures a single user 
interaction with the website); it is important to note that the session rate is lower than the 
calculation rate, as more than one calculation may be conducted by the same user during 
one session.  Data at the country level are described as accurate worldwide; it is believed 
that access via mobile devices or VPN can lead to inaccuracies in tracking the source, but 
usually within the country of origin (e.g. assigned to the wrong city).  FRAX and NOGG usage 
was computed as the number of sessions originating from within the UK as a whole and also 
examined at nation and city level.  NHS users were classified by the finding of  ?ŶŚƐ ?ŝŶƚŚĞIP 
address assigned to the source accessing the websites. 
The number of sessions over the index period of one year (1st July 2013 to 30th June 2014) 
was divided by the population over the age of 50 years for the year 2015 using demography 
from the UN [UN 2015] (medium variant) and expressed as calculations/million.  
 
RESULTS 
During the one year period a total of 1,773,812 sessions was recorded on the FRAX website 
from all users around the world.  The UK was the second largest user in terms of absolute 
numbers of sessions (Table 1), with 19.7% of the total sessions originating from there.  The 
majority of UK sessions (284,686, 81.6%) arose from service providers identified as within 
the National Health Service.   
During the same period, there was a total of 253,530 sessions recorded on the NOGG 
website with the majority of these (208,766; 82.3%) arising from within the UK (Table 1).  
Two-thirds (67.4%) of the latter were classified as returning users by Google Analytics.  NHS-
based service providers were again identified as the major source of UK sessions (166,859; 
79.9%) on the NOGG website.  Of the remaining 44,764 sessions on the NOGG website, half 
were from users in the United States (Table1).   
 
 
Table 1.  Usage of the FRAX and NOGG websites according to the absolute number of 
sessions from the top 5 countries in the year 1st July 2013 to 30th June 2014. 
  
FRAX NOGG 
Country Total sessions Country Total sessions 
1 United States of America 753,262 (675) United Kingdom 208,766 (891) 
2 United Kingdom 348,964 (1489) United States of America 22,591 (20) 
3 Japan 65,338 (114) Ireland 2,986 (149) 
4 Canada 61,215 (455) Slovenia 2,378 (289) 
5 Spain 57,033 (319) Canada 1,948 (14) 
 
For UK users, the FRAX and NOGG sites both showed a strong weekly pattern of access with 
low rates at the weekend and substantially higher rates Monday to Friday (Figure 1).  For 
example, the FRAX website showed an average of 956 sessions per day but this comprised 
an average of 1282 sessions per weekday and an average of 137 per day at the weekend.  
The daily average number of sessions on the NOGG website was 572, comprising an average 
of 773 sessions per weekday and an average of 68 per day at the weekend. 
 
 
 
 
 
Figure 1.  Weekly pattern of use of the FRAX and NOGG websites by UK-based users during 
the period 1st July 2013 to 30th June 2014.  Bars represent the mean number of sessions 
recorded on each site. 
 
 
 
Of the UK-sourced sessions, the majority on both the FRAX (77.6%) and NOGG (78.4%) 
websites were from England (Table 2).  It is important to note that after adjustment for the 
populations of each nation aged 50 years and over, the session rate (per million) was highest 
for Scotland with lowest rates seen in Wales and Northern Ireland and intermediate rates in 
England.   
  
Table 2.  Usage of the FRAX and NOGG websites within the UK according to the absolute 
number of sessions and session rate (sessions per 1,000,000 of population aged 50 years and 
over) in the year 1st July 2013 to 30th June 2014. 
 
Country 
FRAX 
sessions 
NOGG 
sessions 
Population 
aged 50 and 
over 
FRAX 
session rate 
NOGG 
session rate 
England 270,748 163,749 14,829,804 18,257 11,042 
Scotland 55,999 32,740 1,936,000 28,925 16,911 
Wales 14,384 7,677 1,155,951 12,443 6,641 
Northern 
Ireland 
7,784 4,586 574,215 13,556 7,986 
 
 
Geographical data within GoogleAnalytics demonstrated widespread usage of both websites 
throughout most of England and the more densely populated areas of Wales, Scotland and 
Northern Ireland.  The pattern of locations was virtually identical for both websites 
suggesting concomitant use of FRAX and NOGG (data not shown).  The 15 top ranking cities 
and towns in the UK for absolute numbers of sessions to the FRAX website and the same 
locations ? visits to the NOGG website are shown in Table 3.  Sessions on the NOGG website 
as a proportion of sessions on the FRAX website varied from 48.1% in Cardiff to 71.3% in 
Manchester.    
 
Table 3.  The top 15 UK cities and towns accessing the FRAX and NOGG websites in the 12 
month period.  The number of NOGG sessions is also expressed as a proportion of the total 
FRAX sessions from each location. 
 
Ranking City/Town 
FRAX 
Sessions 
NOGG 
Sessions 
NOGG/FRAX 
(%) 
1 London 59,376 30,351 51.1 
2 Sheffield 44,639 30,131 67.5 
3 Glasgow 44,161 25,788 58.4 
4 Manchester 22,008 15,695 71.3 
5 Leicester 15,420 9,810 63.6 
6 Cardiff 11,944 5,743 48.1 
7 York 11,692 6,614 56.6 
8 Nottingham 10,099 6,994 69.3 
9 Oxford 9,275 5,003 53.9 
10 Tamworth 7,244 4,756 65.7 
11 Edinburgh 6,605 3,945 59.7 
12 Belfast 6,361 3,676 57.8 
13 Derby 5,848 3,878 66.3 
14 Chelmsford 5,766 3,503 60.8 
15 Norwich 5,055 3,319 65.7 
 
Nearly all (95.7%) of the NOGG sessions from the UK arose from calculations being passed 
through from the FRAX tool for guidance on the interpretation of FRAX probabilities.  This 
comprised FRAX calculations in patients without a BMD measurement (155,000; 74.5%) or 
FRAX calculations with a BMD result (44,000; 21.2%).  A minority of sessions was conducted 
for other reasons (manual calculations, document downloads, FAQs etc.).   
 
DISCUSSION 
Our analysis suggest that there is good linkage between the use of the FRAX fracture risk 
ĂƐƐĞƐƐŵĞŶƚƚŽŽůĂŶĚƚŚĞEĂƚŝŽŶĂůKƐƚĞŽƉŽƌŽƐŝƐ'ƵŝĚĞůŝŶĞ'ƌŽƵƉ ?ƐĂĚǀŝĐĞŽŶŵĂŶĂŐĞŵĞŶƚŽĨ
osteoporosis in the UK.  The majority of use arises from within NHS facilities and most 
calculations using the FRAX tool are undertaken in the absence of BMD, presumably as an 
initial assessment of fracture risk in line with NICE guidance[13].  Bearing in mind that a 
single session may include calculations on more than one individual, the data would suggest 
that the FRAX tool is being used to assess fracture risk in almost 1300 people each weekday 
in the UK.  At least 750 people have their osteoporosis management passed through the 
NOGG website on each weekday.   
While there is wide provision of clinical guidelines in many chronic diseases, the uptake and 
use of such guidance varies enormously.  There are many hurdles to overcome in optimising 
the use of guidance, ranging from awareness of its existence to implementation and impact 
on individual care.  Low awareness will always result in low adherence but, even with 
detailed plans and processes for implementation, clinician knowledge of such guidelines is 
relatively low world-wide for osteoporosis[18-21] and other chronic diseases.  Education is 
obviously important but its effectiveness can be disappointing; for example, a Cochrane 
review reported that continuing medical development meetings led to only relatively small 
improvements in practice and patient outcomes[22]. The wider use of electronic health care 
systems and health records may lead to improved adherence to clinical guidance due to 
automation.  Certainly computer-generated reminders appear to improve adherence to 
protocols[23].  A number of guidelines also provide clinical decision support systems, usually 
in the form of software programs, to assist with uptake and implementation.  Such point-of-
care computerised advice has been shown to improve treatment with a variety of drugs, 
including anticoagulants, insulin, and antibiotics[24].  The FRAX and NOGG websites have 
incorporated some of these methods.  For example, both are discussed frequently at clinical 
education meetings in the UK as well as in regular published updates that are provided free 
through the NOGG website.  The NOGG guidance has also been endorsed by a large number 
of appropriate clinical and patient societies.  Prompts and reminders are built into the 
system; for example, if a FRAX risk assessment for a 76 year old woman with a prior fracture 
is passed through to the NOGG website, an automated reminder pops up to remind the 
clinician that such a patient can be considered for treatment in the absence of a BMD 
measurement.   One might argue that the result from FRAX should automatically trigger the 
transfer of the result to the NOGG website but this remains voluntary and at the discretion 
of the clinician.  It is notable however that the use of the NOGG website is almost entirely 
driven by FRAX activity.  The reason for the higher use of FRAX and NOGG in Scotland 
compared to elsewhere in the UK is unclear.  The use is evenly distributed across the major 
population centres in Scotland, suggesting that this does not reflect a different policy in one 
city or region of the country.  One might speculate that it could relate to more limited access 
to densitometry services, but we currently have no data to support this suggestion.   
Our study has several limitations.  Whilst showing widespread usage of both tools, the 
metric that we have captured is visits to the websites from within the UK.  Each of these 
visits or sessions may contain one or more calculations and therefore underestimates the 
number of risk assessments.  Some measure of this can be garnered from the difference 
between the number of actual calculations per annum on the FRAX website (captured by a 
dedicated calculation counter on the website) and the total session number.  The counter 
has recorded 2.6-2.7 million calculations per year for the last several years but the total 
number of sessions in 2013-14 was only approximately 1.8 million.  A further limitation is 
that the web site is not the sole portal for the calculation of fracture probabilities.  For 
example, FRAX is available on BMD equipment and on smartphones.  Website activity will 
not capture usage of FRAX on bone densitometers and, therefore, provides an additional 
underestimate of the number of risk assessments.  As stated previously, mobile 
phone/computer usage may lead to incorrect geographical allocation, albeit usually within 
the same country.  In addition, the analysis captured sessions on the FRAX website from 
visitors located within the UK, but some of these may have been using calculators other than 
the UK calculator.  This would occur, for example, in the case of ethnic minority or immigrant 
patients within the UK where current evidence suggests that the use of national tools may 
be inaccurate and the use of more ethnic-appropriate calculators is advised[25].  This may 
provide, at least in some part, an explanation for the greater use of FRAX than NOGG as the 
latter is only available on the UK calculation tool.   
The present analysis cannot determine whether the use of FRAX and NOGG is always 
targeted to appropriate people (i.e. those with risk factors), and it is not possible to say what 
proportion of the at-risk population is assessed.  Finally, we are unable to examine the 
impact of the combined use of FRAX and NOGG on treatment uptake and/or fracture 
reduction in those at highest risk.  This important question is, however, being addressed in a 
large, 7-centre, randomised study comprising over 13000 women aged 70-85 years in the UK, 
funded by MRC and ARUK.  The Screening for Osteoporosis in Older People (SCOOP) study 
will compare treatment uptake and fracture rates in women randomised to receive standard 
care against those in women assessed by the FRAX tool with targeting of intervention based 
on a forerunner of the NOGG thresholds[26].  It is anticipated that this study will report in 
the not too distant future. 
We conclude that this analysis shows widespread and linked use of the FRAX and NOGG 
approaches to assessing and managing fracture risk in people in the UK.  The approach is 
one that could readily be applied in other countries through the existing FRAX models, an 
option that has already been exercised by several countries (e.g. Finland, Lebanon and 
Romania).  The impact on appropriate prescribing and fracture rates should be the focus of 
future studies.     
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